
NAGL MedTech™ brings leading-edge medical technology to market through a talented staff of accomplished engineers and specialists. NAGL MedTech™ offers product development support services with access to equipment, systems, or expertise – all or in part – to help you minimize your investment in capital equipment, business systems, and human capital.
Clients can select from our four distinct ELEVATOR® service offerings ranging from off-site project support to full incubation of their company, from conception to commercialization, at the NAGL MedTech™ facility.
Unlike traditional OEM Manufacturers, NAGL MedTech™ has no interest in locking you into long-term manufacturing contracts based on production volumes. Our interest lies in understanding your incubation program and exit strategy, allowing us to plan together how NAGL MedTech™ can best serve your needs throughout the entire project lifecycle. The ELEVATOR® business model allows each client to develop and foster an ongoing relationship based on exceptional medical design and cost-effective solutions.
Our sole focus here at NAGL MedTech™ is to bring leading-edge medical technology ideas to life, through the work of our passionate associates. From neuro-catheter systems, robotic surgery devices, and more, NAGL MedTech™ truly shapes the future through the research, design, and commercialization of industry-changing technology.
We are industry changers. A group of people that come together every day to work towards a better tomorrow for everyone.
Our Vision
To provide The Disney experience to the MedTech industry worldwide.
Our Mission
Provide a path for MedTech companies around the world to meet their business objectives through the innovative service offerings, proprietary development recipes, and cost-effective production capabilities.
Our Values
- Accountability
- Passion
- Innovation
- Client Focus
- Character
- Growth
Our History
2002
Started Naglreiter Consulting LLC
2011
Expanded staff to 3 associates
2012
Leased 1,000 sq. ft. space and quality system, and opened first operations within Innovia LLC
2013
Moved headquarters to Miramar, expanded to 3,500 sq. ft., and increased associates to 7
2014
Expanded space to 6,000 sq. ft., made $600k in captial investments, initiated NCL quality system development, and increased associates to 13
2015
Expanded space to 10,000 sq. ft., made $800k in additional capital investments, certified the quality system, and increased associates to 25
2016
Made additional capital investments of $700k, validated sterilization cycle, and increased associates to 40
2017
Finalized marketing campaign and increased associates to 56
2018
Expanded Strategic Partnerships and invested an additional $650k in equipment and system integration. Increased associates to 63.
Expanded leased space from 10,000 sq. ft to 17,000 sq. ft.
2019
Made additional $400k investment in two fully incubated companies.
Invested $300k in equipment and system improvements. Associate count hits triple digits – increased to 102.
2020
Reduced workforce head count from 102 to 55 due to COVID-19.
Provided $1M in service loans to incubated companies.
Invested $300K into Endovascular Production Tooling.
2021
Increased workforce head count from 55 to 69 to address rebound in market.
Provided an additional $1.5M in funds to incubated companies.

